BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11885847)

  • 41. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
    Mathew GK; Singh SS; Swaminathan RG; Tenali SG
    J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.
    Oechsle K; Kollmannsberger C; Honecker F; Boehlke I; Bokemeyer C
    Eur J Cancer; 2008 Aug; 44(12):1663-9. PubMed ID: 18620855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
    Meyers RL; Katzenstein HM; Krailo M; McGahren ED; Malogolowkin MH
    J Pediatr Surg; 2007 Dec; 42(12):2050-6. PubMed ID: 18082706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The therapeutic approach to intrathoracic metastases of non-seminomatous testicular tumour.
    Van de Wal H; Arkenbout P; Ten Berge E; Jongerius C; Debruyne F; Lacquet L
    Acta Chir Belg; 1984; 84(6):349-56. PubMed ID: 6524231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical and surgical management of pulmonary metastases from germ cell tumors.
    Xiao H; Liu D; Bajorin DF; Burt M; Bosl GW
    Chest Surg Clin N Am; 1998 Feb; 8(1):131-43. PubMed ID: 9515178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
    Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of primary malignant germ cell tumor of the mediastinum.
    Sakurai H; Asamura H; Suzuki K; Watanabe S; Tsuchiya R
    Jpn J Clin Oncol; 2004 Jul; 34(7):386-92. PubMed ID: 15342665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term results of multimodality therapy of testicular germ cell tumor].
    Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
    Fléchon A; Culine S; Théodore C; Droz JP
    Eur Urol; 2005 Dec; 48(6):957-63; discussion 963-4. PubMed ID: 16084010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
    Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
    Petersen RP; Pham D; Toloza EM; Burfeind WR; Harpole DH; Hanish SI; D'Amico TA
    Ann Thorac Surg; 2006 Jul; 82(1):214-8; discussion 219. PubMed ID: 16798217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
    Ong TA; Winkler MH; Savage PM; Seckl MJ; Christmas TJ
    BJU Int; 2008 Jul; 102(2):198-202. PubMed ID: 18294302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.